“…The rectovaginal septum, rectosigmoid colon, vagina, and pelvic peritoneum represented the majority of extragonadal sites. Other locations include: bowel, umbilicus, lymph node, urinary tract, pleura, diaphragm, lung, etc (Slavin et al, 2000;Van Gorp et al, 2004;Yantiss et al, 2001). Two possible explanations for the relation-ship between endometriosis and intraperitoneal cancer have been proposed: (i) endometriotic implants undergo malignant transformation secondary to genetic defects (p53 mutations) (Akahane et al, 2007) that also serve to enable the endometriosis to thrive, or (ii) women with endometriosis have a defect in their immune system that enables the endometriosis to flourish, and this baseline defect leaves them more susceptible to subsequent malignant transformation (Modesitt et al, 2002).…”